TSHA- Taysha Gene Therapies, Inc.

Name: Taysha Gene Therapies, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Taysha Gene Therapies, Inc. (TSHA) has 8 insiders with recent SEC Form 4 filings, including 7 buys and 7 sells. TSHA is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
10%	Manning Paul B	2.84M	$19.35M	-
CFO	Alam Kamran	1.44M	$9.82M	-
Dir	Stalfort John A III	1.16M	$7.87M	-
Pres	Nagendran Sukumar	1.12M	$7.61M	-
CEO	Nolan Sean P.	648.0K	$4.41M	-

Activity

Buys and sells only

Transactions

10 filings · page 2

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Aug 16, 2023	Manning Paul B53	10% Owner	Buy	16,466,667	$0.90	$14,820,000.30	New	-31.1%	+18.7%
Aug 16, 2023	Stalfort John A III	Director	Buy	777,778	$0.90	$700,000.20	+70.3%	-31.1%	+18.7%
Aug 16, 2023	Nolan Sean P.	Chief Executive Officer	Buy	444,444	$0.90	$399,999.60	+40.7%	-31.1%	+18.7%
Aug 16, 2023	Donenberg Phillip B.	Director	Buy	111,111	$0.90	$99,999.90	+3,704%	-31.1%	+18.7%
Jul 13, 2023	Session R.A. II	10% Owner	Sell	85,872	$0.71	$60,770.73	-0.5%	+252.9%	+238.6%
Jun 23, 2023	Session R.A. II	10% Owner	Sell	28,608	$0.70	$20,119.13	-0.2%	+359.1%	+348.5%
Jun 21, 2023	Session R.A. II	10% Owner	Sell	434,615	$0.71	$307,843.98	-2.3%	+365.6%	+294.2%
May 16, 2023	Nagendran Sukumar49	President And Head Of R&D	Buy	5,000	$0.68	$3,400.00	+17.1%	+207.8%	+349.4%
Oct 31, 2022	Manning Paul B53	Director, 10% Owner	Buy	1,500,000	$2.00	$3,000,000.00	+1,055%	-10.5%	+36.0%
Aug 23, 2022	Alam Kamran83	Chief Financial Officer	Sell	3,325	$3.47	$11,537.75	-1.2%	-36.0%	-36.0%

← PrevPage 2Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC